The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa

被引:2
作者
Qu, Qianqian [1 ]
Qian, Qi [1 ]
Shi, Jiejing [1 ]
Liu, Haiyan [1 ]
Zhang, Yan [1 ]
Cui, Wenhao [2 ]
Chen, Ping [2 ]
Lv, Haidong [1 ]
机构
[1] Peoples Hosp Jiaozuo City, Dept Neurol, Jiaozuo, Henan, Peoples R China
[2] Xinxiang Med Univ, Grad Sch, Xinxiang, Henan, Peoples R China
关键词
glycogen storage disease type III; glycogen debrancher enzyme; gene mutation; skeletal muscle MRI; AGL gene; MANAGEMENT; DIAGNOSIS;
D O I
10.3389/fneur.2020.554012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the clinical features, skeletal muscle imaging, and muscle pathological characteristics of late-onset GSD IIIa caused by mutation of the AGL gene in adults. Methods: The clinical data, skeletal muscle imaging, pathological data, and gene test results of a family with late-onset GSD IIIa in adulthood were collected in detail in November 2019. Results: The proband is a 40-years-old male, who was admitted into our hospital due to a 2-years history of limb weakness. The proband was diagnosed with the following syndrome: he had a 15-years history of elevated muscle enzymes; the cranial nerve examinations showed no abnormal findings; the muscle tension in both upper and lower limbs was low, and tendon reflexes were absent; the proband's muscle strength was 5 in the proximal muscles and 4 in the distal muscles of the upper limbs, with 3 in the proximal muscles and 4 in the distal muscles of the lower limbs; Magnetic Resonance Imaging (MRI) revealed abnormally high signal intensity changes in the posterior thigh muscle group, and the posterior-medial calf muscle group; and vacuoles were evident in some muscle fibers biopsied from the gastrocnemius muscle. Periodic acid-Schiff staining stained the cytoplasm of muscle fibers a dark red color. The proband's older brother exhibited the same clinical features. DNA analysis identified mutations in the AGL gene in the proband, his older brother, and parents. The proband and his older brother both carried two compound heterozygous mutations, c.866G>A and c.2855_2856insT. Pedigree analysis demonstrated that c.866G>A and c.2855_2856insT mutations had been inherited from the mother and father, respectively. Conclusion: Late-onset GSD IIIa in adults is clinically characterized by muscle weakness, muscle atrophy, and mainly occurred in the posterior thigh muscle group. We also identified two novel compound heterozygous mutations (c.866G> A and c.2855_2856insT) in the AGL gene.
引用
收藏
页数:7
相关论文
共 19 条
[1]   Neuromuscular Involvement in Glycogen Storage Disease Type III in Fifty Tunisian Patients: Phenotype and Natural History in Young Patients [J].
Ben Chehida, Amel ;
Ben Messaoud, Sana ;
Ben Abdelaziz, Rim ;
Ben Ali, Nadia ;
Boudabous, Hela ;
Ben Abdelaziz, Ines ;
Ben Ameur, Zeineb ;
Sassi, Yosra ;
Kaabachi, Neziha ;
Abdelhak, Sonia ;
Abdelmoula, Mohamed Slim ;
Fradj, Mohamed ;
Azzouz, Hatem ;
Tebib, Neji .
NEUROPEDIATRICS, 2019, 50 (01) :22-30
[2]  
Chinese medical association neurology branch Chinese medical association neurology branch neuromuscular disease group Chinese medical association neurology branch electromyography and clinical nerve electrophysiology group, 2016, ZHONGHUA SHENJINGKE, V49, P8, DOI [10.3760/cma.j.issn.1006-7876.2016.01.003, DOI 10.3760/CMA.J.ISSN.1006-7876.2016.01.003]
[3]  
CORI GT, 1952, J BIOL CHEM, V199, P661
[5]   Molecular analysis of the AGL gene: Identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III [J].
Goldstein, Jennifer L. ;
Austin, Stephanie L. ;
Boyette, Keri ;
Kanaly, Angela ;
Veerapandiyan, Aravind ;
Rehder, Catherine ;
Kishnani, Priya S. ;
Bali, Deeksha S. .
GENETICS IN MEDICINE, 2010, 12 (07) :424-430
[6]   PERIPHERAL NEUROPATHY IN GLYCOGEN STORAGE DISEASE TYPE III: FACT OR MYTH? [J].
Herlin, Bastien ;
Laforet, Pascal ;
Labrune, Philippe ;
Fournier, Emmanuel ;
Stojkovic, Tanya .
MUSCLE & NERVE, 2016, 53 (02) :310-312
[7]   Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III [J].
Jauze, Louisa ;
Monteillet, Laure ;
Mithieux, Gilles ;
Rajas, Fabienne ;
Ronzitti, Giuseppe .
HUMAN GENE THERAPY, 2019, 30 (10) :1263-1273
[8]   Gene therapy for glycogen storage diseases [J].
Kishnani, Priya S. ;
Sun, Baodong ;
Koeberl, Dwight D. .
HUMAN MOLECULAR GENETICS, 2019, 28 (R1) :R31-R41
[9]   Glycogen Storage Disease Type III diagnosis and management guidelines [J].
Kishnani, Priya S. ;
Austin, Stephanie L. ;
Arn, Pamela ;
Bali, Deeksha S. ;
Med, Anne Boney ;
Case, Laura E. ;
Chung, Wendy K. ;
Desai, Dev M. ;
El-Gharbawy, Areeg ;
Haller, Ronald ;
Smit, Peter A. ;
Smith, Alastair D. ;
Hobson-Webb, Lisa D. ;
Wechsler, Stephanie Burns ;
Weinstein, David A. ;
Watson, Michael S. .
GENETICS IN MEDICINE, 2010, 12 (07) :446-463
[10]   Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment [J].
Laforet, Pascal ;
Inoue, Michio ;
Goillot, Evelyne ;
Lefeuvre, Claire ;
Cagin, Umut ;
Streichenberger, Nathalie ;
Leonard-Louis, Sarah ;
Brochier, Guy ;
Madelaine, Angeline ;
Labasse, Clemence ;
Hedberg-Oldfors, Carola ;
Krag, Thomas ;
Jauze, Louisa ;
Fabregue, Julien ;
Labrune, Philippe ;
Milisenda, Jose ;
Nadaj-Pakleza, Aleksandra ;
Sacconi, Sabrina ;
Mingozzi, Federico ;
Ronzitti, Giuseppe ;
Petit, Francois ;
Schoser, Benedikt ;
Oldfors, Anders ;
Vissing, John ;
Romero, Norma B. ;
Nishino, Ichizo ;
Malfatti, Edoardo .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)